Cargando…
Efficacy comparison of duloxetine and SSRIs at doses approved in Japan
BACKGROUND: Approved doses of antidepressants in Japan are usually lower than those in the USA and European Union, but to date meta-analyses comparing antidepressants have all used the higher doses approved in the USA and European Union and often have used indirect comparisons. The purpose of this s...
Autores principales: | Harada, Eiji, Schacht, Alexander, Koyama, Tsukasa, Marangell, Lauren B, Tsuji, Toshinaga, Escobar, Rodrigo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4296960/ https://www.ncbi.nlm.nih.gov/pubmed/25624763 http://dx.doi.org/10.2147/NDT.S72642 |
Ejemplares similares
-
Treatment discontinuation and tolerability as a function of dose and titration of duloxetine in the treatment of major depressive disorder
por: Harada, Eiji, et al.
Publicado: (2016) -
Analysis of HAM-D scores and working ability in an observational study of Japanese patients with major depressive disorder and painful physical symptoms treated with duloxetine or SSRI monotherapy
por: Kuga, Atsushi, et al.
Publicado: (2019) -
Duloxetine in patients with diabetic peripheral neuropathic pain in Japan: a randomized, doubleblind, noninferiority comparative study with pregabalin
por: Enomoto, Hiroyuki, et al.
Publicado: (2018) -
An observational study of duloxetine versus SSRI monotherapy for the treatment of painful physical symptoms in Japanese patients with major depressive disorder: primary analysis
por: Kuga, Atsushi, et al.
Publicado: (2017) -
Association between pain severity, depression severity, and use of health care services in Japan: results of a nationwide survey
por: Vietri, Jeffrey, et al.
Publicado: (2015)